Gefitinib vs Insulin Glargine

Gefitinib vs Insulin Glargine: Overview

This comparison examines the pharmacological differences between Gefitinib and Insulin Glargine.

Mechanism of Action

Gefitinib: Selective reversible inhibitor of EGFR tyrosine kinase.

Insulin Glargine: Long-acting insulin analogue that binds insulin receptors.

Pharmacokinetics

Half-life: Gefitinib — 48 hours; Insulin Glargine — 12-24 hours.

Chemical Properties

Molecular Formula: Gefitinib — C22H24ClFN4O3.

Molecular Weight: Gefitinib — 446.9000 g/mol.

Type: Gefitinib — Small molecule; Insulin Glargine — Protein.